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Abstract: We have designed imidazolium and piperazinium salts of pyropheophorbide-a 
in order to develop effective photosensitizers which have good solubility in polar and non 
polar media and to reveal the possible influences of the piperazine and imidazole moieties 
on the biological activities of pyropheophorbide-a.  The phototoxicity of those 
pyropheophorbide-a salts against A549 cells was studied in vitro and compared with that 
of pyropheophorbide-a. The result showed that complexing piperazine and imidazole into 
pyropheophorbide-a decreases its dark toxicity without greatly decreasing phototoxicity 
and, enhances its phototoxicity without greatly increasing dark toxicity, respectively. This 
work not only describes novel amphiphilic salt complexes of pyropheophobide-a which 
retain the biological activities of the parent compound pyropheophorbide-a and could be 
effective candidate for PDT, but also reveals the possibility of developing effective 
photosensitizers by complexing imidazole and piperazine into other hydrophobic 
photosensitizers. 
 
Keywords:  piperazinium salts; imidazolium salts; pyropheophorbide-a; photodynamic 
therapy. 
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1. Introduction 
 
Photodynamic therapy (PDT) is a binary cancer therapy that relies on the selective uptake of a 
photosensitizer in tumor tissues, followed by generation of singlet oxygen and other cytotoxic species 
upon irradiation with light of an appropriate wavelength [1-2]. Singlet oxygen is considered to be the 
main cytotoxic species generated in PDT. It has a limited range of diffusion within tissues and it 
readily reacts with a variety of electron rich biomolecules such as unsaturated lipids, amino acids and 
DNA at the site of its generation. Although a number of studies have documented preferential uptake 
of photosensitizers in tumor tissues, the exact mechanism of PDT is not fully understood [3-5]. There 
are several possible approaches to explain preferential accumulation of photosensitizers in tumor cells 
relating to cellular specificity such as lower pH media and more low-density lipoprotein (LDL) 
receptors in malignant tissue than those in the normal tissue [6]. 
In order to find optimal photosensitizers, different compounds have been synthesized and examined 
including porphyrins, chlorins, phthalocyanines and purpurins [7-8]. Among them, chlorins represent 
the second generation of photosensitizers with promising physicochemical properties and high PDT 
efficiency [9-11]. 
 Although one of the important prerequisites that photosensitizers should have is their amphiphilic 
property, most of chlorins are hydrophobic due to their hydrophobic macrocycle. If a photosenzitizer 
has too high lipophilicity, it has trouble to pass through blood vessels after intravenous injection. On 
the other hand, if a photosensitizer has too high hydrophilicity, it is difficult to penetrate cell 
membrane. Therefore it is important to compromise between hydrophilicity and lipophilicity. 
Introduction of hydrophilic groups imparts chlorin molecules with amphiphilic properties and, 
therefore, with good solubility in polar and non polar media. Such properties provide some chlorin 
derivatives with good tumor/tissue ratio, high tumor efficacy and short clearance time [12]. 
There have been several studies of protoporphyrin and chlorin e6 which are complexed with 
hydrophilic organic amine such as N-methyl-D-glucamine and arginine to improve their solubility in 
physiological solutions, while only few reports have been observed in the literature on 
pyropheophorbide-a derivatives complexed with hydrophilic organic amine used as a photosensitizer 
for PDT [13-14]. However, there is no research about salt formations between pyropheopheorbide-a 
and imidazole/piperazine. Therefore, we hypothesized that if we incorporated imidazole and 
piperazine into effective but hydrophobic photosensitizers, it may be possible to develop effective and 
amphiphilic photosensitizers without decreasing biological activities of parent chlorins in account of 
specific properties of imidazole and piperazine. 
In this study, we aimed to develop effective photosensitizers which have good solubility in polar 
and non polar media while retaining the biological activities of the hydrophobic parent 
photosensitizers. Accordingly, we have designed two new salts of pyropheophorbide-a in which 
piperazine and imidazole groups, chosen as a hydrophilic organic amine, were non-covalently 
complexed to the propionic acid residue of pyropheophorbide-a. A comparative study of their 
photodynamic activities on A549 cancer cells was carried out in order to reveal influences of 
piperazine and imidazole moieties on biological activities of pyropheophorbide-a. 
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2. Results and Discussion 
 
We have synthesized methyl pheophorbide-a (MPa) from Spirulina pacifica biomass by the 
procedure reported by Smith et al., followed by further conversion into pyropheophorbide-a (PPa) by a 
two step chemical procedure including pyrolysis of MPa with 2,4,6-collidine and hydrolysis of methyl 
pyropheophorbide- a [15-17]. 
The piperazinium and imidazolium salts of pyropheophorbide-a (PSP and ISP, respectively) were 
obtained by treating PPa with the organic free bases piperazine and imidazole, respectively. It is 
shown that formation of a salt bond between the carboxy group of the parent chlorin and the amine 
groups of piperazine and imidazole is a simple and effective method to obtain PPa salt-like complexes  
(Scheme 1). The 
1H-NMR spectrum of PSP showed a broad singlet at 7.2 for the piperazine ring amine 
group protons, a singlet at 2.08 ppm for the piperazine ring imine group protons and also multiplets at 
3.51-3.42 ppm for the protons of the four piperazine ring methylene groups, whereas ISP showed a 
broad singlet at 8.11 ppm for the imidazole ring imine group protons and singlets at 7.66 and 7.02 ppm, 
respectively, for the imidazole ring 2-position methine proton and the 4 and 5 position methine protons. 
Moreover, the chemical shifts for all protons of ISP appeared at slightly higher fields than those of 
PSP and Ppa. According to the 
1H-NMR data, the formation of quaternary nitrogen on the imidazole 
and piperazine rings were confirmed by appearance of the characteristic peaks for imine and amine 
groups, respectively, on the rings. 
 
Scheme 1. Synthetic pathways of piperazinium salt of pyropheophorbide-a (PSP) and 
imidazolium salt of pyropheophorbide-a (ISP).  
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2.1. Dark toxicity 
 
The biological activity of PSP and ISP were evaluated in contrast to that of PPa in A549 human 
lung adenocarcinoma cells. An important prerequisite that a photosensitizer should have is a low dark 
toxicity when it is not irradiated. We therefore measured the dark toxicity of PSP and ISP by means of 
an MTT assay when cells treated by those compounds and untreated control cells kept in dark without 
any irradiation. After 3 h and 24 h of incubation in the dark, percentage of viable cells in each sample 
was measured by MTT assay (Figure 1). 
 
Figure 1. Dark toxicity of PSP (dash-“triangle”-dash), ISP (dot-“circle”-dot), starting 
material PPa (line-“square”-line) and control (dash-dot-“diamond”-dash-dot) toward 
A549 cells in dark without any irradiation for 3 h (A) and 24 h (B) incubation time. 
 
 
 
 
 
 
 
 
 
 
 
At low concentrations, namely less than 3 μM, cells were not affected by the treatment with all 
compounds, whereas at concentrations more than 3 μM, all compounds exhibited a significant 
cytotoxic effect in A549 cells. Moreover dark toxicity of ISP was higher than those of PSP and PPa at 
concentrations more than 3 μM after 3h and 24 h incubation whereas the toxic effect induced by PSP 
was very lower than that of PPa at concentration more than 3 μM after 3 h and 24 h. To distinguish 
their dark toxicity effect quantitatively, we have evaluated the IC90 for each compound, which were 
4.2 (ISP), 7.1 (PPa) 14.8 μM (PSP) after 3 h and, 4.1 (ISP), 5.3 (PPa) 7.2 μM (PSP) after 24 h, 
respectively. Determined IC90 values of compounds confirming that PSP exhibited drastically less 
toxic effect than both of ISP and PPa after 3h and 24 h incubation time. 
 
2.2. Phototoxicity 
 
We measured the phototoxicity of PSP, ISP and PPa at concentrations of 1.25, 2.5, 5, 10 and 20 μM 
in A549 cells when cells treated by those compounds and untreated control cells were irradiated with a 
2 Jcm
-2 light dose. The percentage of viable cells was evaluated by MTT assay at 3 h and 24 h 
incubation time after PDT with increasing concentrations of those compounds as shown in Figure 2. 
Percentage of cell viability decreased with increasing concentration of agents for all 
photosensitizers. For 3 h incubation after PDT, ISP exhibited enhanced phototoxicity than starting 
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material PPa at all concentrations whereas PSP showed decreased phototoxicity compared to PPa at all 
concentrations, except for 1.25 μM. In the 24 h incubation time case, the phototoxicity of ISP was 
higher than that of PSP at all concentrations, whereas PSP showed more phototoxicity than PPa at 
concentrations of more than 5 μM. 
According to the dark and phototoxicity study of PSP and ISP comparing with PPa, PSP exhibited 
not only low dark toxicity but also high phototoxicity at concentrations of 1.25 μM, whereas ISP 
exhibited high phototoxicity for all concentrations, but showed slightly higher dark toxicity only for 
high concentrations. The increasements of dark and phototoxicity for ISP may be explained by specific 
properties of imidazole which is involved in anticancer and antibacterial medications [18-19]. 
 
Figure 2. Phototoxicity of PSP (dash-“triangle”-dash), ISP (dot-“circle”-dot), starting 
material PPa (line-“square”-line) and control (dash-dot-“diamond”-dash-dot) toward 
A549 cells using 2 J cm
-2 dose light for 3 h (A) and 24 h (B) incubation time after PDT. 
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Figure 3. Optical image of morphological changes induced by PSP (b and c) and ISP (e 
and f) for 24 and 48 h respectively after irradiation compared with control (a and d) at 
2.5x10
-6 M concentration. 
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The phototoxicity of those compounds was also examined by monitoring cell death at 3 and 24 h 
incubation after photoirradiation under microscopic observation. Figure 3 shows the micrographs of 
A549 cells death at the concentration of 2.5 x 10-6 M and at different points of time after PDT. No cell 
death was observed without the agent, whereas cell death was observed at increased concentration of 
PSP and ISP. The leakage of the cytoplasm became more significant with time course and blebs were 
formed on the cell surface, indicating injury of the cell. 
3. Conclusions 
 
In summary, we have synthesized new amphiphilic photosensitizers which are soluble in water and 
non-polar media by complexing hydrophilic organic amines, namely imidazole and piperazine, with 
water-insoluble hydrophobic pyropeophorbide-a. Phototoxicity studies of those newly synthesized 
complexes have been performed to reveal the influence of the piperazine and imidazole moieties on 
the biological activities of pyropheophorbide-a. The results showed that complexation with piperazine 
and imidazole decreases the dark toxicity of pyropheophorbide-a without greatly decreasing 
phototoxicity and enhances its phototoxicity without greatly increasing dark toxicity, respectively. 
This work not only describes new, water-soluble salt complexes of pyropheophobide-a which retain 
the biological activities of the parent compound and could be effective candidates for PDT, but also 
shed a light on the development of promising amphiphilic photosensitizers by complexing other 
effective but hydrophobic photosensitizers with imidazole and piperazine. We are further investigating 
those amphiphilic salts for PDT to explore their aggregation in blood vessel after intravenous injection 
and their penetration and accumulation into cancer cells. 
 
4. Experimental Section  
 
4.1. Materials 
 
Absorption spectra were measured in CH2Cl2 using a SCINCO S-3100 spectrophotometer. 
1H-
NMR spectra (300 MHz) were measured in CDCl3 solutions with TMS as internal standard using a 
UNITYplus-300 spectrometer (Busan Center of the Korean Basic Science Institute, Busan National 
University, Korea); chemical shifts are expressed in ppm relative to TMS (0.00). Silica gel 60A (230-
400 mesh, Merck) was used for column chromatography. All reactions were monitored by thin-layer 
chromatography (TLC) using Merck 60 silica gel F254 precoated (0.2 mm thickness) glass-backed 
sheets. All chemicals, including imidazole, piperazine, MeOH, CH2Cl2, KOH, THF, SO4H2 and 1,3,5-
collidine were analytical grade. Phosphate buffered saline (PBS, Sigma-Aldrich), a microscope 
(Olympus, CK40-32 PH, Japan), ELISA-reader (BioTek, Synergy HT, USA), trypsin-EDTA solution, 
and incubator (37°C, 5% CO2) were also used. 
 
4.2. Synthesis of methyl pheophorbide-a 
 
Dried Spirulina Pacifica alga (500 g) was refluxed in acetone (2 L) under nitrogen for two hours. 
The supernatant was filtered. The extraction and filtration process was repeated three times. The green Int. J. Mol. Sci. 2008, 9                 
 
 
1413
filtrate was evaporated and treated with 5% SO4H2 in MeOH for 12.5 hours at room temperature in the 
dark under nitrogen. After that, reaction mixture was treated with CH2Cl2, rinsed with water, 10% 
aqueous NaCO3H solution, and again with water three times. The organic layer was separated and 
dried over anhydrous Na2SO4 and evaporated to dryness. The residue was purified by column 
chromatography on silica gel eluting with 2% acetone in CH2Cl2 and the product was re-crystallized 
from CH2Cl2-MeOH. Methyl pheophorbide-a was thus obtained in 0.4% yield. 
 
4.3. Synthesis of the piperazinium salt of PPa (PSP) 
 
To a solution of PPa (0.1 mmole) in MeOH/CH2Cl2 (3:1, 10 mL), a solution of piperazine (0.1 
mmole) in MeOH/water (1:2, 20 mL) was added and the mixture stirred about 2 hours. The organic 
solvents were evaporated under vacuum and the resulting aqueous solution was filtered through a 
membrane (20 μm) and freeze dried to give the piperazinium salt of PPa. λmax(CH2Cl2) 667.3 nm; δH : 
9.42 (1 H, s, H-5), 9.32 (1 H, s, H-20), 8.51 (1 H, s, H-10), 8.01 (1 H, m, H-3
1 ), 7.20 (2H, s, H-NH2-
pip), 6.28 and 6.16 (2H, d, H-3
2), 5.30 and 5.09 (2 H, d, H-15
1), 4.46 (1 H, q, H-18), 4.26 (1 H, d H-
17), 3.75 (2H, q, H-8
1), 3.60 (3 H, s, H-12), 3.51-3.41 (8H, m, H-CH2-pip), 3.36 (3 H, s, H-1
1), 3.24 (3 
H, s, H-7
1), 2.7 (2 H, m, H-17
1), 2.62 (2 H, m, H-17
2), 2.08 (1H, br, NH-pip), 1.78 (3 H, d, H-18
1), 
1.67 (3 H, t, H-8
2, J = 7.6 Hz, 7
2 Me), 0.88 (1 H, br, H-NH); -1.72 (1H, br, H-NH). 
 
4.4. Synthesis of the imidazolium salt of PPa (ISP) 
 
To a solution of PPa (0.1 mmole) in MeOH/CH2Cl2 (3:1, 10 mL), a solution of imidazole (0.1 
mmole) in MeOH/water (1:2, 20 mL) was added and the mixture stirred about 2 hours. The organic 
solvents were then evaporated under vacuum. The resulting aqueous solution was filtered through a 
membrane (20 μm) and freeze dried to give the imidazolium salt of PPa. λmax(CH2Cl2)/nm 667.1 nm; 
δH : 9.20 (1 H, s, H-5), 9.14 (1 H, s, H-20), 8.42 (1 H, s, H-10), 8.11 (2H, s, H-NH-imi), 8.01 (1 H, m, 
H-3
1 ), 7.66 (1H, s, H
2-imi), 7.03 (2H, s, H
4 and H
5 -imi), 6.19 and 6.08 (2H, d, H-3
2), 5.28 and 5.03 (2 
H, d, H-15
1), 4.41 (1 H, q, H-18), 4.19 (1 H, d H-17), 3.72 (2H, q, H-8
1), 3.45 (3 H, s, H-12), 3.27 (3 
H, s, H-1
1), 3.08 (3 H, s, H-7
1), 2.64 (2 H, m, H-17
1), 2.37 (2 H, m, H-17
2), 1.73 (3 H, d, H-18
1), 1.58 
(3 H, t, H-8
2, J = 7.6 Hz, 7
2 Me), 0.87 (1 H, br, H-NH), -1.77 (1H, br, H-NH). 
 
4.5. Cell culture and photoirradiation 
 
The cell line tested was A549 (human lung carcinoma cell), which was obtained from the cell line 
bank at Seoul National University’s Cancer Research Center (Korea) and grown in RPMI-1640 
medium (Sigma-Aldrich) with 10% fetal bovine serum, glutamine, penicillin and streptomycin at 37
0C 
in a humidified atmosphere of 5% CO2 in air. The PDT was carried out using irradiation (BioSpec 
LED, Russia). The wavelength was set at an appropriate level depending on absorption maximum of 
the photosensitizer. Duration of the light irradiation, under PDT treatment, is calculated taking into 
account of the empirically found effective dose of light energy in J cm
-2. 
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4.6. Morphological changes induced by PDT 
 
Cells from each cell line were inoculated into a 96-well chamber slide at a volume of 100 μL (5 × 
10
4 cells/well) for stationary culture. Twenty-four h later, photosensitizer (2.5 μM, 100 μL/well) was 
then added. After a predetermined time, the photosensitizer solution was discarded and the culture was 
again washed (x 3) with physiological saline and medium added to a volume of 100 μL/well. The 
cultures were then subjected to LED irradiation at the distance of 20 cm for 10 min, and examined by 
optical microscopy 3 h and 24 h later to determine the morphologic changes induced, compared with 
the cultures not subjected to irradiation. The time course of the changes in survival rate after 
irradiation was observed. 
 
4.7. Cell viability 
 
Cells from each cell line were inoculated into a 96-well, flat-bottomed microplate at a volume of 
100 μL (1 × 10
5 cells/well) for stationary culture. Forty-eight hours later, the medium was removed, 
and the cultures were washed three times with physiologic saline. Amounts of photosensitizer solution 
(0.3, 0.6, 1.25, 2.5 and 5.0 μM) were then added at a volume of 100 μL/well, respectively. Twenty-
four hours later, the photosensitizer solution was discarded, and the cultures were again washed three 
times with physiological saline and then medium was added to a volume of 100 μL/well. The cultures 
were then subjected to the irradiation (2 J cm
-2) at the distance of 20 cm for 10 min, followed by an 3-
(4,5-dimethylthiazole-2-yl)-2,5-biphenyl tetrazolium bromide (MTT) assay to evaluate their sensitivity 
to PDT. For the MTT assay, MTT solution (10 μL) was added to each cell-culture well and cultured in 
the incubator for 3 h. Detergent solution (TACS™, Trevigen, 200 μL) was added to the culture, 
shaken for 10 min, and the absorbance was measured with an ELISA-reader at 570 nm. Measurements 
were performed 3 h and 24 h after the irradiation. Each group consisted of three wells. 
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